Emergent bimodal firing patterns implement different encoding strategies during gamma-band oscillations

por Sancristóbal, B., Vicente, R., Sancho, J. M., Garcia-Ojalvo, J.
Publicado 2013

P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELI...

por Sancho, J.-M., Lopez-Guillermo, A., Abrisqueta, P., Kumar, A., Cordoba, R., Tani, M., Zhao, W., Rappold, E., Langmuir, P., Mims, M.
Publicado 2022

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CI...

por Hamadani, M., Coleman, M., Boccia, R., Duras, J., Hutchings, M., Zinzani, P. L., Cordoba, R., Oreiro, M. B., Williams, V., Stouffs, M., Langmuir, P., Sancho, J.-M.
Publicado 2022

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy...

por González-Barca, E., Canales, M., Salar, A., Ferreiro-Martínez, J. J., Ferrer-Bordes, S., García-Marco, J. A., Sánchez-Blanco, J. J., García-Frade, J., Peñalver, J., Bello-López, J. L., Sancho, J. M., Caballero, D.
Publicado 2016

P1189: INITIAL SAFETY RUN-IN RESULTS OF THE PHASE III POLARGO TRIAL: POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE L...

por McMillan, A., Haioun, C., Sancho, J.-M., Viardot, A., Rodriguez Izquierdo, A., Donato Martin, E. M., García-Sancho, A. M., Sandoval-Sus, J., Tilly, H., Vandenberghe, E., Hirata, J., Choudhry, P., Chang, Y. M., Musick, L., Matasar, M.
Publicado 2022

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

por Karube, K, Enjuanes, A, Dlouhy, I, Jares, P, Martin-Garcia, D, Nadeu, F, Ordóñez, G R, Rovira, J, Clot, G, Royo, C, Navarro, A, Gonzalez-Farre, B, Vaghefi, A, Castellano, G, Rubio-Perez, C, Tamborero, D, Briones, J, Salar, A, Sancho, J M, Mercadal, S, Gonzalez-Barca, E, Escoda, L, Miyoshi, H, Ohshima, K, Miyawaki, K, Kato, K, Akashi, K, Mozos, A, Colomo, L, Alcoceba, M, Valera, A, Carrió, A, Costa, D, Lopez-Bigas, N, Schmitz, R, Staudt, L M, Salaverria, I, López-Guillermo, A, Campo, E
Publicado 2018

P1128: CLINICAL FEATURES AND OUTCOME OF PATIENTS WITH CASTLEMAN DISEASE: A SPANISH MULTICENTRIC STUDY OF 134 PATIENTS FROM GELTAMO

por Navarro, J. T., Celades, C., García, O., González-Barca, E., Climent, F., Feu, A., Jiménez, A., Gutiérrez de la Peña, A., Bastos-Oreiro, M., Aldamiz-Echevarria, T., Gutiérrez, A., Bento, L., Abrisqueta, P., Alonso, C. M., Tejada Chavez, C., Ocio, E. M., Fernández Escalada, N., Navarro Matilla, M. B., Mateos Pérez, J. M., López-García, A., Castillo-Girón, C., Pinzón, S. F., Pérez Ceballos, E., Hernández Rivas, J. Á., del Campo García, R., Pardal de la Mano, E., García-Sanz, R., Rovira, J., Sancho, J. M., Tapia, G.
Publicado 2022